News from perrigo company plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 13, 2019, 09:29 ET Perrigo to Present at the Morgan Stanley Global Consumer & Retail Conference

Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will present at the Morgan...


Nov 06, 2019, 06:00 ET Perrigo Company plc Reports Third Quarter 2019 Financial Results

Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-Care ProductsTM", today announced financial results...


Nov 04, 2019, 09:31 ET Perrigo Announces Quarterly Dividend

Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that its Board of...


Oct 23, 2019, 16:06 ET Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the product

As a precautionary measure, Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has initiated a voluntary, worldwide product recall to the ...


Oct 15, 2019, 08:05 ET Perrigo Announces Third Quarter Calendar Year 2019 Earnings Date

Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its third quarter calendar year 2019 financial results on Wednesday,...


Oct 03, 2019, 17:18 ET Perrigo® Hosts 175 West Michigan Students for Manufacturing Week Celebration

Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", opened its doors for more than 175 high...


Oct 03, 2019, 08:00 ET Perrigo Announces the Relaunch of the AB Rated Generic Version of Transderm Scop® 1.5 MG

Perrigo Company plc (NYSE; TASE: PRGO) today announced the relaunch of the AB rated generic equivalent of Transderm Scop® (scopolamine 1.5 mg)....


Sep 05, 2019, 08:30 ET Perrigo Advances Consumer Self-Care Growth Strategy With Acquisition Of Prevacid®24hr

Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® ...


Aug 22, 2019, 07:48 ET Perrigo To Present At Upcoming Investor Conferences

Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will host one-on-one meetings ...


Aug 21, 2019, 08:42 ET Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal® Nasal Spray

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has settled its Hatch-Waxman litigation relating to Nascobal® (Cyanocobalamin) Nasal...


Aug 08, 2019, 06:30 ET Perrigo Company plc Reports Second Quarter 2019 Financial Results, Reaffirms Outlook, Progresses Consumer Transformation

GAAP ("reported") net sales were $1.15 billion, reflecting a 3% decline versus the prior year period. Non-GAAP ("adjusted") net sales increased by...


Aug 07, 2019, 16:50 ET Perrigo Announces Resignation Of Jeffrey C. Smith From Its Board Of Directors

Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", today announced that Jeffrey C. Smith,...


Jul 31, 2019, 09:52 ET Perrigo Announces Quarterly Dividend

Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that its Board of...


Jul 25, 2019, 09:17 ET Perrigo Announces Second Quarter Calendar Year 2019 Earnings Date

Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its second quarter calendar year 2019 financial results on Thursday,...


Jul 08, 2019, 16:12 ET Perrigo Completes Divestiture of Animal Health Business for $185 Million

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to...


Jul 03, 2019, 08:37 ET Perrigo Announces FDA Final Approval and Launch Of The AB-rated Generic Version Of Metrogel-Vaginal® Gel

Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug...


Jul 02, 2019, 08:51 ET Perrigo Completes Acquisition Of Ranir, Raises Guidance

Perrigo Company plc (NYSE; TASE: PRGO) today announced the successful completion of its acquisition of Ranir Global Holdings LLC ("Ranir"), the...


May 21, 2019, 09:12 ET Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren® Gel 1%

Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S. Food and Drug Administration for its AB...


May 09, 2019, 07:30 ET Perrigo Unveils Self-Care Transformation Plan, 2019 Guidance And Long-Term Growth Targets At Investor Day

Perrigo Company plc (NYSE; TASE: PRGO) today is holding its Investor Day at the New York Stock Exchange in New York City, outlining its strategy to...


May 09, 2019, 07:00 ET Perrigo To Expand Into Adjacent Self-Care Category By Acquiring Ranir Global Holdings LLC, The Leading Global Private Label Supplier Of Oral Self-Care Products

Perrigo Company plc (NYSE, TASE: PRGO) today announced that it has reached a definitive agreement to purchase privately-held Ranir Global Holdings...


May 08, 2019, 17:07 ET Perrigo Company plc Reports First Quarter 2019 Financial Results, Begins Consumer Self-Care Transformation

GAAP ("reported") net sales were $1.2 billion, reflecting a 4% decline versus the prior year period, or down 1% excluding the unfavorable impact of...


May 08, 2019, 16:09 ET Perrigo To Divest Animal Health Business For $185 Million In Cash As Part Of Consumer Self-Care Transformation

Perrigo Company plc (NYSE; TASE: PRGO), today announced that it has reached a definitive agreement to sell its Animal Health business to PetIQ...


May 01, 2019, 16:13 ET Perrigo Announces First Quarter Calendar Year 2019 Earnings Date And Upcoming Conference Participation

Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its first quarter calendar year 2019 financial results on May 8, 2019...


Apr 26, 2019, 09:03 ET Perrigo Increases Its Dividend By 11%

Perrigo Company plc (NYSE; TASE: PRGO), today announced that the company's Board of Directors, consistent with its recently approved strategic plan...


Apr 18, 2019, 16:15 ET Perrigo To Host Investor Day

Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of Quality, Affordable Self-Care Products™, today announced that it will hold its...